Elektrofi: Funding, Investors & Team (Oct 2026)
Elektrofi is a preclinical-stage organization devoted to reclassifying the norm of medication conveyance by changing the patient experience. Elektrofi's definition framework can really handle a large number of remedial particles. Their innovation has the ability to handle huge, progressively mind boggling and fragile proteins including monoclonal antibodies, bispecifics and combination proteins. Established in 2016, Elektrofi is situated in Boston, Massachusetts, United States.
Elektrofi has raised $152M across 2 funding rounds on record, the most recent a Series C of $112M announced in Aug 2024.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Elektrofi Company Profile and Key Stats
Latest funding round on record: Aug 2024.
Elektrofi Funding Rounds
Elektrofi raised $40.0M in a Series B announced in Jun 2022.
2.2 years later, a Series C of $112M was announced in Aug 2024.
Elektrofi Founders and Leadership Team
Contact details for the Elektrofi team: 1 of 1 has an email address on file.
Start 14-day free trial →Elektrofi Funding Compared to Other Biotechnology Startups
Elektrofi's latest round of $112M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Elektrofi in Biotechnology and Boston
Companies Similar to Elektrofi
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Elektrofi Funding FAQs
What does Elektrofi do?
Elektrofi is a preclinical-stage organization devoted to reclassifying the norm of medication conveyance by changing the patient experience. Elektrofi's definition framework can really handle a large number of remedial particles. Their innovation has the ability to handle huge, progressively mind boggling and fragile proteins including monoclonal antibodies, bispecifics and combination proteins. Established in 2016, Elektrofi is situated in Boston, Massachusetts, United States.
How much funding has Elektrofi raised?
Elektrofi has raised $152M across 2 rounds on record. The most recent is a Series C of $112M announced in Aug 2024.
When did Elektrofi last raise funding?
Elektrofi's most recent funding round on record is a Series C of $112M, announced in Aug 2024.
Who founded Elektrofi?
FundedIQ lists Chase Coffman (Founder) at Elektrofi.
Where is Elektrofi headquartered?
Elektrofi is based in Boston, Massachusetts, United States.
How many employees does Elektrofi have?
Elektrofi is in the 11-50 employee band.
How does Elektrofi's funding compare to other Biotechnology startups?
Elektrofi's latest round of $112M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Elektrofi Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Elektrofi is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.